Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Stop cutting patients off their prescribed benzodiazepines

Christy Huff, MD
Meds
January 2, 2020
3K Shares
Share
Tweet
Share

In the wake of the opioid epidemic, benzodiazepines have been called “our other prescription drug problem” and “the next U.S. drug crisis.” Prescriptions are on the rise, with over 30 million Americans reporting benzodiazepine use in the previous year. This is alarming, as benzodiazepines are implicated in at least 30% of opioid overdose deaths and have serious risks of their own, such as car accidents, falls, physical dependence, and dementia.

Combining benzodiazepines and opioids causes respiratory depression, increasing the risk of fatal overdose tenfold compared to the use of opioids alone. In 2016, the FDA issued a boxed warning advising extreme caution when combining these drug classes. The 2016 CDC Guideline for Prescribing Opioids for Chronic Pain also addressed co-prescription, stating: “Clinicians should avoid prescribing opioid pain medication and benzodiazepines concurrently whenever possible.”

The CDC Guideline further says: “there are circumstances when it might be appropriate to prescribe opioids to a patient receiving benzodiazepines.” But in the current climate, the recommendation to avoid co-prescribing is often treated as law, and physicians and pharmacies are being pressured to curb the practice.

This is contributing to another crisis: Patients being forced off long-term benzodiazepines, often with serious consequences. Lori Ann G., a professional billiards player from Arizona, was cut off her 17-year Klonopin prescription by a doctor who simply no longer wanted the liability of prescribing benzodiazepines. The dangers of acute benzodiazepine withdrawal are well known: seizures and even death. Thirty-six hours after her last dose of Klonopin, Lori Ann experienced multiple seizures, and her blood pressure was “off the charts,” landing her in the emergency room. She had two more ER visits in 30 days, each time asked by staff: “Are you here for pills?” Finally, during her third visit, a physician recognized that she was in benzodiazepine withdrawal and gave her only enough Valium for a 30-day taper.

Lori Ann’s withdrawal was unbearable: “My heart was jumping out of my chest. My hearing was blown. My eyesight was completely blurred. I thought I was literally dying.” Involuntary clenching of her jaw shattered three molars.

Even when benzodiazepines are not stopped abruptly, patients are often forced to taper too quickly. Yvonne Gibney, a former office manager from New Mexico and a chronic pain patient, had filled the same prescriptions for Dilaudid and Ativan for years. But in 2017, her pharmacy’s new policy prohibited dispensing a benzodiazepine with an opioid. Yvonne found another pharmacy to dispense Ativan, but her doctor became nervous and cut her dose by half, initiating a taper to be done in two months’ time.

Withdrawal symptoms are a natural consequence of stopping or precipitously lowering a long-term benzodiazepine dose. Yet the diagnosis of benzodiazepine withdrawal is often missed: patients are assumed to be “drug-seekers” and withdrawal goes untreated. Yyonne returned to her doctor’s office a few days after her Ativan reduction with clear withdrawal symptoms, sweating, shaking, and crying. Her doctor refused to slow her taper rate and referred her to an addiction clinic, which performed drug testing and asked questions implying she was seeking pills. After several calls to her doctor pleading for help, Yvonne was dropped from his practice.

Patients who survive rapid benzodiazepine discontinuation may face severe and debilitating symptoms. And in a subset, these can persist for years after the last dose — a “protracted withdrawal syndrome” more accurately described as neurological injury. Two years after her rapid taper, Yvonne remains extremely ill. She is emaciated, having lost much of her muscle mass. She has frozen shoulders and severe contractures in her hands. She has extreme nerve pain she describes as a “sandblaster across my entire body,” causing her to stand 18 hours a day to avoid unbearable skin contact with furniture. She is completely reliant on her husband to care for her. Yvonne contemplates suicide daily as a means of escape from her symptoms.

As for Lori Ann, six years after her last Valium dose, she remains unable to work. Her short-term memory has been so damaged from rapid withdrawal that she uses Post-It notes to remind herself that she is cooking. She lives alone, and caring for herself is a struggle.

The benzodiazepine problem goes beyond concerns of overprescribing. Physicians receive little to no education on how to properly taper benzodiazepines, and that is resulting in serious harm. Patients like Yvonne and Lori are left gravely ill, with little support from their doctors, and they aren’t alone: my nonprofit receives hundreds of emails monthly from benzodiazepine patients abandoned by their doctors or forced to taper too quickly.

Patients on long-term benzodiazepines should be handled with care. There is no one-size-fits-all approach to withdrawing from this class of drug. A proper benzodiazepine taper can take many months or even years (one to two months is not enough for many). Even guidelines that recommend a “slow” taper may be too fast for some: the CDC Guideline, for example, recommends that benzodiazepines be reduced by 25% every one to two weeks, whereas many patients in online withdrawal forums find they must taper less than 10% of their current dose monthly to keep symptoms tolerable. While the Ashton Manual on tapering benzodiazepines is a good starting point, the rate of withdrawal should ultimately be determined by the patient’s symptoms. Not only does this alleviate patient suffering, but it also decreases the risk of neurological injury that can occur with abrupt removal of the drug.

Regarding opioids, in response to forced and rapid tapers, the CDC issued a statement earlier this year advising against misapplication of their guidelines: “The Guideline does not support abrupt tapering or sudden discontinuation of opioids. These practices can result in severe opioid withdrawal symptoms.” Similarly, the FDA warned: “Health care professionals should not abruptly discontinue opioids in a patient who is physically dependent … Create a patient-specific plan to gradually taper the dose.” Given the examples above, and many other unfortunate (and preventable) outcomes we have seen, it seems obvious these statements should be applied to benzodiazepines as well.

Christy Huff is a cardiologist and co-director, Benzodiazepine Information Coalition. She can be reached on Twitter @christyhuffMD.

Image credit: Shutterstock.com

Prev

Is health care just legal human trafficking?

January 2, 2020 Kevin 1
…
Next

Speaking to cancer as if it were a person

January 2, 2020 Kevin 0
…

Tagged as: Medications, Psychiatry

Post navigation

< Previous Post
Is health care just legal human trafficking?
Next Post >
Speaking to cancer as if it were a person

More by Christy Huff, MD

  • The updated benzodiazepine boxed warning: What you need to know

    Christy Huff, MD
  • A Xanax prescription that should have been rejected

    Christy Huff, MD
  • Don’t miss this adverse drug reaction when tapering benzodiazepines

    Christy Huff, MD

Related Posts

  • Are patients using social media to attack physicians?

    David R. Stukus, MD
  • How the war on opioids has harmed some patients

    Angelika Byczkowski
  • You are abandoning your patients if you are not active on social media

    Pat Rich
  • Your patients are counting on you

    Adam Striker, MD
  • People who take opioids are the AIDS patients of today

    Heather Finlay-Morreale, MD
  • 5 hidden consequences of chronic pain

    Toni Bernhard, JD

More in Meds

  • The real cause of America’s opioid crisis: Doctors are not to blame

    Richard A. Lawhern, PhD
  • Can personalized medicine live up to its hype in health care?

    Ketan Desai, MD, PhD
  • The effects of the nationwide stimulant shortage on a private psychiatry practice

    Christine Tran-Boynes, DO
  • Why North American medical cannabis can’t compete globally

    Michael Sassano
  • How were we duped and what can we do about the opioid overdose crisis?

    Ronald A. Zent, MD
  • Caught in the middle: How health insurance companies influence cancer drug selection

    Paul Pender, MD
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy
    • Breaking the stigma: Addressing the struggles of physicians

      Jean Antonucci, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • The realities of immigrant health care served hot from America’s melting pot

      Stella Cho | Policy
    • The dark side of immortality: What if we could live forever?

      Ketan Desai, MD, PhD | Physician
    • Lazarus: the dead man brought back to life

      William Lynes, MD | Conditions
    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
    • What I think it means to be a medical student in the wake of AI

      Jackson J. McCue | Tech
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 17 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Our Organ Transplant System Isn't the Failure It's Made Out to Be
  • 2-Minute Clinic: Can You Name This Disease of the Female Reproductive System?
  • Blood Thinner Recall; Marburg Cases Triple; E. Coli in Meat May Cause 500,000 UTIs
  • Sam Neill's Rare Lymphoma
  • Day in the Life of a Doctor: Treating a Patient With Septic Shock

Meeting Coverage

  • Switch to IL-23 Blocker Yields Deep Responses in Recalcitrant Plaque Psoriasis
  • Biomarkers of Response With Enfortumab Vedotin in Advanced Urothelial Cancer
  • At-Home Topical Therapy for Molluscum Contagiosum Gets High Marks
  • Outlook for Itchy Prurigo Nodularis Continues to Improve With IL-31 Antagonist
  • AAAAI President Shares Highlights From the 2023 Meeting
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy
    • Breaking the stigma: Addressing the struggles of physicians

      Jean Antonucci, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • The realities of immigrant health care served hot from America’s melting pot

      Stella Cho | Policy
    • The dark side of immortality: What if we could live forever?

      Ketan Desai, MD, PhD | Physician
    • Lazarus: the dead man brought back to life

      William Lynes, MD | Conditions
    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
    • What I think it means to be a medical student in the wake of AI

      Jackson J. McCue | Tech
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Stop cutting patients off their prescribed benzodiazepines
17 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...